TACC3 and plasma cell myeloma: Once again, this sequence was derived from a leukemia cell line, not from a normal tissue counterpart, suggesting that mutations in TACC3 may also be a feature of other hematological malignancies, in addition to the previously documented aberrant expression observed in multiple myeloma [46].